Health plans and self-insured employers often use reinsurance (also known as stop-loss coverage) to limit their aggregate exposure to medical costs or to control the costs of a single episode. A new report from Milliman describes the current reinsurance market. (Milliman Report) The report covered 24 insurers with $8.6 billion in premium, out of a total market of around $15 billion. Sun Life, Symetra and Tokio Marine were identified as the most prominent independent carriers and most of the large health plan companies also offer employers reinsurance, although those health plan competitors often in turn purchase reinsurance. A number of significant new entrants are expected, many of which are well-established insurers in other lines. This may result in greater price competition and reduced profitability. Most reinsurers said health was a focus area and 58% said premium revenue grew 6% or more during 2016 and 50% expect growth of 12% or more in 2018 and 2019. Loss ratios were around 77% in 2016. Commissions for broker-placed reinsurance averaged about 3% to 5%. Independent reinsurers were more likely to rely on brokers than were health plans which offered reinsurance. About 58% of policies start on January 1, and another 13% on July 1. Some emerging or popular features of policies include the ability to aggregate specific deductibles, mirroring of the underlying policy and dividend or experience-based premium refunds. Some carriers are offering coverage for pharmacy-only claims, which may be a strong future trend given specialty drug costs. 60% of reinsurance premiums come from policies with $150,000 or lower individual claim deductibles and 75% of premium revenue is derived from employers of 1000 workers or fewer. Health plans that offer reinsurance tend to have greater stickiness of clients from year-to-year than do independent reinsurers. As health care spending continues to increase, particularly among the most expensive cases, the reinsurance market should also see continued growth.
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
No Need for More CV-19 Vax Doses
February 5, 2025
No Need for More CV-19 Vax Doses
Studies continue to show essentially no benefit from additional doses of CV-19 vax.
Commentary
OK, Here We Go with New Job Numbers for the New Administration
February 4, 2025
OK, Here We Go with New Job Numbers for the New Administration
Nothing super dramatic in the first JOLTS release of 2025.
Commentary
Does Anyone Really Not Understand Trump at this Point?
February 4, 2025
Does Anyone Really Not Understand Trump at this Point?
What happened over three days in regard to tariffs was totally predictable if you understand…